Recombinant DNA (IBC)
Office of Research and Technology Transfer
The Institutional Biosafety Committee (IBC) of The University of Texas At Tyler (UT Tyler) reports on matters related to the use of recombinant deoxyribonucleic acid (rDNA) technology in research, clinical and educational activities at UT TYLER. The committee is charged with ensuring full compliance with NIH Guidelines for Research Involving Recombinant DNA Molecules, referred to herein as the NIH Guidelines.
Policies and Procedures
- IBC Policies and Procedures
- Experiments Exempt from IBC Review
- Investigator Responsibilities for the Use of rDNA
- IBC Processing Flowchart
- Request for Approval Form (Use of Cultured Cells and Recombinant DNA)
- NIH Guidelines
All Principal Investigators, Co-Investigators, and Students involved with this area of research are required to complete and pass the following training modules.